Increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs) are expected to propel the growth of this market.
What the Market Looks Like?
Predicted to grow at a CAGR of 4.3% during the forecast period, the GlobalSugar Excipients Market is estimated to reach USD 1,060.6 Million by the end of 2021. Europe is the largest regional segment for the global market.
Based on type, the market is segmented into powders/granules, direct compression sugars, crystals, and syrups. Similarly, on the basis of functionality, the market is segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities.
Based on formulation, this market is segmented into oral formulations, parenteral formulations, topical formulations, and other formulations.Based on regions, the Sugar Excipients Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Growth in this market can be attributed to factors such as increasing use of co-processed excipients, rapid growth in the generics market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODTs).
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242342136
What Drives the Market?
The growth of the global market for sugar excipients is primarily influenced by the following factors:
- Increasing Use of Co-Processed Excipients
·Patent Cliffs Driving the Demand for Sugar Excipients in the Generics Market
·Increasing Development of Orally Disintegrating Tablets (ODTS)
- Shifting Focus of Pharmaceutical Manufacturing to Emerging Countries
Geographical growth scenario ofSugar Excipients Market:
Geographically, the global Sugar Excipients Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the global market. Europe’s largest share is primarily attributed to the increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region. North America represents the second largest market for sugar excipients.
Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=242342136
Leading market players and strategies adopted
The prominent players in the Sugar Excipients Market include Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), Ashland Inc. (U.S.), Archer Daniels Midland Company (U.S.), MEGGLE AG (Germany), Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), and The Lubrizol Corporation (U.S.).
DFE Pharma (Germany) held the second-largest share in the Sugar Excipients Market in 2015. In the Sugar Excipients Market, the company is largely known for its diversified lactose offerings for the pharmaceutical industry. Its position among the top sugar excipient manufacturers is attributed to its global footprint through distributors and agents. The company is highly focused on expansion of its functional units in emerging countries.